American Funds Global Balanced Fd Cl F-1 (GBLEX) Comparison with companies in other sectors?

American Funds Global Balanced Fd Cl F-1 has a share price of 754.70M. You can analyze American Funds Global Balanced Fd Cl F-1 (GBLEX) competitors across different market sectors through stock heatmaps.

What are GBLEX's NET and operating margins?

American Funds Global Balanced Fd Cl F-1 (GBLEX) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does GBLEX's earnings per share (EPS) trend reflect its financial momentum?

American Funds Global Balanced Fd Cl F-1 (GBLEX) EPS is 1.94 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for American Funds Global Balanced Fd Cl F-1 is 21.60, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for American Funds Global Balanced Fd Cl F-1?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for American Funds Global Balanced Fd Cl F-1 like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

American Funds Global Balanced Fd Cl F-1

GBLEX•NASDAQ

Financial Services

Asset Management - Global

$41.92

$0.02(0.05%)

U.S. Market is Open • 14:07

American Funds Global Balanced Fd Cl F-1 Fundamental Analysis

American Funds Global Balanced Fd Cl F-1 (GBLEX) shows weak financial fundamentals with a PE ratio of 21.60, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze GBLEX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze GBLEX's fundamental strength across five key dimensions:

Efficiency Score

Weak

GBLEX struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

GBLEX shows balanced valuation metrics.

PE < 25

21.60

PEG Ratio < 2

N/A

Growth Score

Moderate

GBLEX shows steady but slowing expansion.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

GBLEX carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

GBLEX struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is GBLEX Expensive or Cheap?

P/E Ratio

GBLEX trades at 21.60 times earnings. This indicates a fair valuation.

21.60

How Well Does GBLEX Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How GBLEX Stacks Against Its Sector Peers

Metric	GBLEX Value	Sector Average	Performance
P/E Ratio	N/A	18.86	N/A
ROE	N/A	847.00%	N/A
Net Margin	N/A	4202.00%	N/A
Debt/Equity	N/A	0.91	N/A
Current Ratio	N/A	667.17	N/A
ROA	N/A	-21543.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews American Funds Global Balanced Fd Cl F-1's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

American Funds Global Balanced Fd Cl F-1 Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is GBLEX Expensive or Cheap?

How Well Does GBLEX Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How GBLEX Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

American Funds Global Balanced Fd Cl F-1 (GBLEX) Comparison with companies in other sectors?

What are GBLEX's NET and operating margins?

In what way does GBLEX's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for American Funds Global Balanced Fd Cl F-1?

How do I know if AAPL is overvalued or undervalued?